Patents by Inventor Thomas David Kay Brown

Thomas David Kay Brown has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of tylvalosin as antiviral agent
    Patent number: 9649324
    Abstract: The Invention relates to the use of antibiotic, tylvalosin, as an anti-viral agent. Tylvalosin is particularly useful for the treatment of PRRSV.
    Type: Grant
    Filed: June 8, 2015
    Date of Patent: May 16, 2017
    Assignees: ECO ANIMAL HEALTH LIMITED, CAMBRIDGE UNIVERSITY TECHNICAL SERVICES
    Inventors: Albert Philip Adrian Mockett, Thomas David Kay Brown, Amanda Denise Stuart
  • USE OF TYLVALOSIN AS ANTIVIRAL AGENT
    Publication number: 20150313929
    Abstract: The Invention relates to the use of antibiotic, tylvalosin, as an anti-viral agent. Tylvalosin is particularly useful for the treatment of PRRSV.
    Type: Application
    Filed: June 8, 2015
    Publication date: November 5, 2015
    Applicants: ECO ANIMAL HEALTH LIMITED, CAMBRIDGE UNIVERSITY TECHNICAL SERVICES
    Inventors: Albert Philip Adrian Mockett, Thomas David Kay Brown, Amanda Denise Stuart
  • Use of tylvalosin as antiviral agent
    Patent number: 9066964
    Abstract: The invention relates to the use of a macrolide antibiotic, tylvalosin, as an anti-viral agent. Tylvalosin is particularly useful for the treatment of PRRSV.
    Type: Grant
    Filed: July 13, 2007
    Date of Patent: June 30, 2015
    Assignees: Cambridge University Technical Services, Eco Animal Health Limited
    Inventors: Albert Philip Adrian Mockett, Thomas David Kay Brown, Amanda Denise Stuart
  • USE OF TYLVALOSIN AS ANTIVIRAL AGENT
    Publication number: 20100010080
    Abstract: The invention relates to the use of a macrolide antibiotic, tylvalosin, as an anti-viral agent. Tylvalosin is particularly useful for the treatment of PRRSV.
    Type: Application
    Filed: July 13, 2007
    Publication date: January 14, 2010
    Applicants: ECCO ANIMAL HEALTH LIMITED, CAMBRIDGE UNIVERSITY TECHNICAL SERVICES
    Inventors: Albert Philip Adrian Mockett, Thomas David Kay Brown, Amanda Denise Stuart
  • DNA encoding the Canine coronavirus spike protein
    Patent number: 5661006
    Abstract: The invention is related to a nucleic acid sequence &coding a Canine coronavirus (CCV) spike protein. Such a protein can be used for the immunization of dogs against CCV infection. The nucleic acid sequence encoding the CCV spike protein can be applied for the preparation of the spike protein by means of genetic engineering techniques or can be applied for the preparation of vector vaccines.
    Type: Grant
    Filed: September 19, 1994
    Date of Patent: August 26, 1997
    Assignee: Akzo Nobel N.V.
    Inventors: Thomas David Kay Brown, Brian Colin Horsburgh